Spectral Domain OCT Documented Resolution of Pseudophakic Cystoid Macular Edema after Intravitreal Triamcinolone

被引:0
|
作者
Murthy, Ravi K. [1 ]
Chalam, Kakarla V. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32611 USA
来源
关键词
CME; Triamcinolone; SD-OCT;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cystoid macular edema (CME) is an important cause of visual loss after cataract surgery. Treatment is usually with topical anti-inflammatory agents, with anti-vascular endothelial growth factor agents and steroids used intravitreally in resistant cases. Even though time-domain Stratus OCT can quantify the macular thickness, it cannot prognosticate visual outcomes due to the poor resolution of images, especially the outer segment-inner segment junction. Spectral-domain OCT (SD-OCT) by its ability to acquire large number of images in a short span of time provides high resolution cross-sectional images of the retina, which not only highlights the underlying pathological changes, but in addition can prognosticate visual recovery. We describe pre and post SD-OCT features of a case of refractory CME who was treated with intravitreal triamcinolone actetonide.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [1] Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema
    Jonas, JB
    Kreissig, I
    Degenring, RF
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (02) : 384 - 386
  • [2] Intravitreal triamcinolone for refractory pseudophakic cystoid macular edema
    Nelson, ML
    Martidis, A
    Spinak, DJ
    Liu, M
    Sivalingam, A
    Federman, JL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U40 - U40
  • [3] Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab
    Rodriguez-Blanco, Maria
    Marticorena, Joaquin
    Gomez-Ulla, Francisco
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (03) : 427 - 428
  • [4] Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab
    María Rodríguez-Blanco
    Joaquin Marticorena
    Francisco Gómez-Ulla
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 427 - 428
  • [5] Intravitreal triamcinolone for recalcitrant pseudophakic or aphakic cystoid macular edema.
    Conway, MD
    Livir-Rallatos, C
    Canakis, C
    Peyman, GA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S685 - S685
  • [6] Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema
    Conway, MD
    Canakis, C
    Livir-Rallatos, C
    Peyman, GA
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2003, 29 (01): : 27 - 33
  • [7] Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
    Chalam, K. V.
    Khetpal, Vijay
    Patel, Chirag J.
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 155 - 158
  • [8] Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion
    Chalam, K. V.
    Keshavamurthy, R.
    Brar, V. S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (05) : 831 - 833
  • [9] Intravitreal bevacizumab for pseudophakic cystoid macular edema
    Carifi, Gianluca
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (03) : 513 - 513
  • [10] Intravitreal Triamcinolone Acetonide Versus Pars Plana Vitrectomy for Pseudophakic Cystoid Macular Edema
    Sevim, Mehmet Sahin
    Sanisoglu, Huseyin
    Turkyilmaz, Kemal
    CURRENT EYE RESEARCH, 2012, 37 (12) : 1165 - 1170